Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis

BackgroundDespite the lack of randomized-controlled trials in patients with failed bioprosthetic valves, valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is increasingly used.MethodsOutcomes of consecutive patients treated with ViV-TAVR (N = 100) at our tertiary heart center between...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteurs:	Michael Paukovitsch, Bartu Dilaver, Dominik Felbel, Marvin Krohn-Grimberghe, Dominik Buckert, Johannes Moerike, Leonhard Moritz Schneider, Christian Liewald, Wolfgang Rottbauer, Birgid Gonska
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2025-04-01
Reeks:	Frontiers in Cardiovascular Medicine
Onderwerpen:	valve in valve aortic replacement bioprosthetic valve degeneration transcatheter aortic replacement device success bioprosthetic valve failure
Online toegang:	https://www.frontiersin.org/articles/10.3389/fcvm.2025.1465409/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis

Gelijkaardige items